4//SEC Filing
Kristal Robert Eugene 4
Accession 0001021771-25-000040
CIK 0001505497other
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 4:26 PM ET
Size
10.2 KB
Accession
0001021771-25-000040
Insider Transaction Report
Form 4
Kristal Robert Eugene
Chief Financial Officer
Transactions
- Award
Stock Option
2025-02-14+166,492→ 166,492 totalExercise: $2.46Exp: 2035-02-14→ Common Stock (166,492 underlying)
Holdings
- 88,968
Stock Option
Exercise: $2.91Exp: 2033-02-17→ Common Stock (88,968 underlying) - 7,994
Common Stock
- 10,490
Stock Option
Exercise: $5.08Exp: 2031-11-04→ Common Stock (10,490 underlying) - 263,158
Stock Option
Exercise: $1.45Exp: 2034-02-13→ Common Stock (263,158 underlying)
Footnotes (4)
- [F1]The option is currently exercisable.
- [F2]The option vests and becomes exercisable to the extent of 44,484 shares on February 17, 2023 with the remaining 44,484 shares vesting in eight nearly-equal quarterly installments beginning on February 17, 2024 and continuing every three months thereafter until fully vested.
- [F3]The option vests and becomes exercisable to the extent of 131,579 shares on February 13, 2024 with the remaining 131,579 shares vesting in eight nearly-equal quarterly installments beginning on February 13, 2025 and continuing every three months thereafter until fully vested.
- [F4]The option vests and becomes exercisable to the extent of 83,246 shares on February 14, 2025 with the remaining 83,246 shares vesting in eight nearly-equal quarterly installments beginning on February 14, 2026 and continuing every three months thereafter until fully vested.
Documents
Issuer
BioRestorative Therapies, Inc.
CIK 0001505497
Entity typeother
Related Parties
1- filerCIK 0001893955
Filing Metadata
- Form type
- 4
- Filed
- Feb 18, 7:00 PM ET
- Accepted
- Feb 19, 4:26 PM ET
- Size
- 10.2 KB